Package 63323-723-03

Brand: remifentanil hydrochloride

Generic: remifentanil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 63323-723-03
Digits Only 6332372303
Product NDC 63323-723
Description

10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-03) / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-01)

Marketing

Marketing Status
Marketed Since 2018-01-19
Brand remifentanil hydrochloride
Generic remifentanil hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "2f27e51f-2b55-47ee-bd4a-001b71c60622", "openfda": {"upc": ["0363323725013", "0363323724016", "0363323723019"], "unii": ["5V444H5WIC"], "rxcui": ["1729578", "1729584", "1729710"], "spl_set_id": ["d2374b84-81c9-44f9-a4a9-1071281b2531"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (63323-723-03)  / 3 mL in 1 VIAL, SINGLE-DOSE (63323-723-01)", "package_ndc": "63323-723-03", "marketing_start_date": "20180119"}], "brand_name": "Remifentanil Hydrochloride", "product_id": "63323-723_2f27e51f-2b55-47ee-bd4a-001b71c60622", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "63323-723", "dea_schedule": "CII", "generic_name": "Remifentanil Hydrochloride", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Remifentanil Hydrochloride", "active_ingredients": [{"name": "REMIFENTANIL HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA206223", "marketing_category": "ANDA", "marketing_start_date": "20180119", "listing_expiration_date": "20261231"}